性能参数

产品名称

Pitavastatin

规格

10mg 25mg

货号

GOY-Y3139

 含量

>98.00%

CAS

147511-69-1

别名

化学名

(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid

分子式

C25H24FNO4

分子量

分子量 421.46

溶解度

≥ 14.35mg/mL in DMSO

储存条件

Store at -20°C

General tips

用途

仅供科研

价格

电询

详细内容

Pitavastatin (NK-104) is a potent HMG-CoA reductase inhibitor, Pitavastatin inhibited cholesterol synthesis from acetic acid with an IC50 of 5.8 nM in a human liver cancer cell line (HepG2).IC50 value: 5.8 nM(cholesterol synthesis from aceticacid in HepG2) [1]Target: HMG-CoA reductasein vitro: Pitavastatin inhibited cholesterol synthesis from aceticacid with an IC50 of 5.8 nM in a human liver cancer cell line (HepG2), which indicates that is 2.9 and 5.7 times as potent as simvastatin and atorvastatin, respectively. When the inhibitory activity interms of the ED50 was compared with that of simvastatin,pitavastatin showed a 3-fold stronger activity in the rat and 15-fold stronger activity in a guinea pig model.22 The inhibitory effect of pitavastatin on sterol synthesis is thought to be liver-selective [1]. pitavastatin reduces total and phosphorylated tau levels in a cellular model of tauopathy, and in primary neuronal cultures. The decrease caused by pitavastatin is reversed by the addition of mevalonate, or geranylgeranyl pyrophosphate. The maturation of small G proteins, including RhoA was disrupted by pitavastatin, as was the activity of glycogen synthase kinase 3β (GSK3β), a major tau kinase [4].in vivo: Intravenous treatment with pitavastatin-incorporated nanoparticles, but not with control nanoparticles or pitavastatin alone, inhibited plaque destabilization and rupture associated with decreased monocyte infiltration and gelatinase activity in the plaque[2].The EAM model was established in BALB/c mice by immunization with murine α-myosin heavy chain. Mice were fed pitavastatin (5 mg/kg) or vehicle once daily for 3 weeks from day 0 to day 21 after immunization [3].

Super-TDU (1-31) TFA  分子量 3355.51mg 5mg 10mg  >98.00%  Cas No. N/A  C141H218N40O48.C2HF3O2

SKL2001  分子量 286.2910mg 50mg 200mg  >99.50%  Cas No. 909089-13-0  C14H14N4O3

SANT-1  分子量 373.510mM (in 1mL DMSO) 10mg 50mg  >99.50%  Cas No. 304909-07-7  C23H27N5

S

BACE-IN-11mg 5mg 10mg 20mg>98.00%Cas No. 1254166-60-3C22H16ClN5O2

Asoxime (chloride)5mg 10mg 25mg 50mg>98.00%Cas No. 34433-31-3C14H16N4O3 ? 2Cl

BAN ORL 24 (hydrochloride)1 mg 5 mg 10 mg 25 mg>98.00%Cas No. 1401463-54-4C27H35N3O2·2HCl

Batefenterol (GSK961081)5mg 10mg 50mg 100mg>98.00%Cas No. 743461-65-6C40H42ClN5O7

Befetupitant (Ro67-5930)1mg 5mg 10mg 20mg>98.00%Cas No. 290296-68-3C29H29F6N3O2